Toshimitsu Hamasaki

Also affiliated with George Washington University, CNR de la Résistance aux Antibiotiques

MathematicsEconomics, Econometrics and FinanceDecision SciencesMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial”.

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

Trials(2022)10.1186/s13063-022-07047-5

N/A

1.4DataRank · unranked

64 citations

Maria Souli, Michael Billard, J Campbell, Douglas Conrad, Damon W. Ellison +20 more

Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00735-6

N/A

0.996DataRank · unranked

25 citations

Nadine Rouphael, Ruxana T. Sadikot, Maria C. Rodriguez‐Barradas, Micah T. McClain, Dana M Wilkins +32 more

Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials

Clinical Infectious Diseases(2022)10.1093/cid/ciac692

N/A

0.557DataRank · unranked

40 citations

Toshimitsu Hamasaki, Weixiao Dai, Deborah Collyar, Daniel B. Rubin, Sumathi Nambiar +12 more

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac140

N/A

0.449DataRank · unranked

19 citations

Weixiao Dai, Dafna Yahav, Toshimitsu Hamasaki, ‪Adi Turjeman‬‏, Fidi Koppel +11 more

Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group

Clinical Infectious Diseases(2023)10.1093/cid/ciad541

N/A

0.348DataRank · unranked

5 citations

Ritu Banerjee, Sarah B. Doernberg, Scott Evans, Lauren Komarow, Michael J. Satlin +28 more

Intention-to-diagnose and distinct research foci in diagnostic accuracy studies

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00070-2

N/A

0.292DataRank · unranked

6 citations

Gene Pennello, Shanshan Zhang, Yixuan Li, Y. Wang, Qian Cao +15 more

Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group

Clinical Infectious Diseases(2023)10.1093/cid/ciad529

N/A

0.165DataRank · unranked

2 citations

Kerryl E. Greenwood‐Quaintance, Maria Souli, Lauren Komarow, Holly Geres, Toshimitsu Hamasaki +6 more

Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review

Clinical Infectious Diseases(2023)10.1093/cid/ciad565

N/A

0DataRank · unranked

6 citations

César A. Arias, Deena R. Altman, Ahmed Babiker, Helen W. Boucher, C. Buddy Creech +40 more

Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs

Clinical Infectious Diseases(2024)10.1093/cid/ciae163

N/A

0DataRank · unranked

4 citations

Ursula Waack, Mark Needles, Daniel B. Rubin, Deborah Collyar, Sarah B. Doernberg +11 more

Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)

UNC Libraries(2024)10.17615/qngy-0518

N/A

0DataRank · unranked

0 citations

Yunyun Jiang, Helen W. Boucher, Paterson D.L., van Duin D., Dean Follmann +13 more

Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group

UNC Libraries(2024)10.17615/f629-ky17

N/A

0DataRank · unranked

0 citations

Satlin M.J., Bonomo R.A., Lodise T.P., Nyssa Schwager, Katherine T. Baum +12 more

A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilities

Scientific Reports(2025)10.1038/s41598-025-04918-0

N/A

0DataRank · unranked

5 citations

Dana K. Pasquale, Heather Henderson, Eric Cober, Sandra S. Richter, Robert A. Salata +42 more

223. Development and Analysis of a Novel DOOR Endpoint for Complicated Intra-abdominal Infections (cIAI) Using 10 Registrational Trials for Antibacterial Drugs

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac492.301

N/A

0DataRank · unranked

0 citations

Ramya Gopinath, Ursula Waack, Mark Needles, Daniel L. Rubin, Deborah Collyar +11 more

Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs

Clinical Infectious Diseases(2023)10.1093/cid/ciad239

N/A

0DataRank · unranked

23 citations

Ramya Gopinath, Ursula Waack, Mark Needles, Daniel B. Rubin, Deborah Collyar +11 more

Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group

Clinical Infectious Diseases(2023)10.1093/cid/ciad547

N/A

0DataRank · unranked

21 citations

David van Duin, Pranita D. Tamma, Thomas P. Lodise, Daria Van Tyne, Keith A. Rodvold +48 more

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Clinical Infectious Diseases(2023)10.1093/cid/ciad576

N/A

0DataRank · unranked

18 citations

Toshimitsu Hamasaki, Weixiao Dai, Deborah Collyar, Daniel B. Rubin, Sumathi Nambiar +24 more

The Future Ain’t What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations

Clinical Infectious Diseases(2023)10.1093/cid/ciad538

N/A

0DataRank · unranked

13 citations

Robin Patel, Toshimitsu Hamasaki, Jessica Howard‐Anderson, Tori Kinamon, H. A. King +36 more

The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions

Clinical Infectious Diseases(2023)10.1093/cid/ciad475

N/A

0DataRank · unranked

9 citations

H. R. Cross, Maria Souli, Scott Evans, Robin Patel, Vance G. Fowler +60 more